Pnc Financial Services Group, Inc. Tg Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

$190 Billion
Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9,019 shares of TGTX stock, worth $321,346. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,019

Previous 7,103 26.97%

Holding current value

$321,346

Previous $213,000 66.67%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$27.67 - $42.99 $53,015 - $82,368	1,916 Added 26.97%	9,019 $355,000
Q4 2024 Feb 07, 2025	SELL	$21.31 - $35.09 $27,042 - $44,529	-1,269 Reduced 15.16%	7,103 $213,000
Q3 2024 Nov 08, 2024	BUY	$17.21 - $25.28 $82,917 - $121,799	4,818 Added 135.57%	8,372 $195,000
Q2 2024 Aug 09, 2024	BUY	$13.32 - $19.19 $13 - $19	1 Added 0.03%	3,554 $63,000
Q1 2024 May 10, 2024	BUY	$13.02 - $21.3 $924 - $1,512	71 Added 2.04%	3,553 $54,000
Q4 2023 Feb 09, 2024	SELL	$6.68 - $18.81 $407 - $1,147	-61 Reduced 1.72%	3,482 $59,000
Q3 2023 Nov 13, 2023	BUY	$8.36 - $26.5 $16,837 - $53,371	2,014 Added 131.72%	3,543 $29,000
Q2 2023 Aug 11, 2023	SELL	$15.48 - $35.0 $1,161 - $2,625	-75 Reduced 4.68%	1,529 $37,000
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $6,751 - $12,764	660 Added 69.92%	1,604 $24,000
Q4 2022 Feb 10, 2023	SELL	$5.01 - $11.83 $2,004 - $4,732	-400 Reduced 29.76%	944 $11,000
Q3 2022 Nov 10, 2022	BUY	$4.57 - $8.4 $530 - $974	116 Added 9.45%	1,344 $7,000
Q2 2022 Aug 12, 2022	BUY	$3.74 - $10.66 $306 - $874	82 Added 7.16%	1,228 $5,000
Q1 2022 May 12, 2022	BUY	$7.81 - $20.45 $164 - $429	21 Added 1.87%	1,146 $10,000
Q4 2021 Feb 11, 2022	SELL	$15.2 - $35.51 $17,844 - $41,688	-1,174 Reduced 51.07%	1,125 $21,000
Q3 2021 Nov 05, 2021	BUY	$21.78 - $40.45 $130 - $242	6 Added 0.26%	2,299 $76,000
Q2 2021 Aug 06, 2021	BUY	$32.5 - $48.96 $40,072 - $60,367	1,233 Added 116.32%	2,293 $88,000
Q1 2021 May 07, 2021	SELL	$41.61 - $54.3 $3,412 - $4,452	-82 Reduced 7.18%	1,060 $51,000
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $3,461 - $7,521	137 Added 13.63%	1,142 $59,000
Q3 2020 Nov 06, 2020	BUY	$18.49 - $27.24 $18,582 - $27,376	1,005 New	1,005 $26,000
Q2 2020 Aug 07, 2020	SELL	$8.9 - $21.84 $8,900 - $21,840	-1,000 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$5.1 - $11.2 $5,100 - $11,200	1,000 New	1,000 $11,000
Q4 2018 Feb 08, 2019	SELL	$3.44 - $5.76 $2,064 - $3,456	-600 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$12.5 - $15.0 $12,500 - $15,000	-1,000 Reduced 62.5%	600 $0
Q1 2018 May 11, 2018	BUY	$8.7 - $16.8 $8,700 - $16,800	1,000 Added 166.67%	1,600 $0
Q3 2017 Nov 13, 2017	BUY	$10.0 - $12.7 $6,000 - $7,620	600	600 $0

Others Institutions Holding TGTX

# of Institutions

416

Shares Held

88.1M

Call Options Held

2.34M

Put Options Held

1.94M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.18B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Tg Therapeutics, Inc. Transaction History